Zoster Eye Disease Study

Completed · Phase 4 · Has a placebo group

Conditions studied: Herpes Zoster Ophthalmicus

In brief

This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.

Key facts

Study ID
NCT03134196
Run by
NYU Langone Health
People needed
527
Starts
2017-08-23
Expected to finish
2024-07-22
Last updated by the study team
2025-03-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.